New Delhi: India’s COVID-19 tally crossed five-lakh mark on Friday (June 26). Within the last six days, one lakh fresh cases were confirmed. According to www.covid19india.org, the total number of confirmed cases are 509,446 and active cases are 197,784. Maharashtra, the worst-hit state has recorded over 5000 new cases in the last 24 hours, taking the total number of confirmed cases to 152,765 with deceased accounting to 79,815.
Tamil Nadu and West Bengal have recorded their biggest single-day hit of 3,645 and 542 respectively. Tamil Nadu’s death toll stands at 41,357 while West Bengal stands at 10,535. Delhi has recorded 3,460 cases in a single day – the total number of confirmed cases has risen to 77,240 while 47,091 people have recovered till now and 2,492 deceased.
The Hyderabad based drugmaker, Hetero has dispatched the first batch of the generic version of the experimental COVID-19 drug, ‘Remdesivir’ to the five worst-hit states – Delhi, Gujarat, Tamil Nadu and Maharashtra. Telangana’s capital Hyderabad, where the drugmaker is based, will also receive the first consignment.
A 100-milligram vial of the drug will cost Rs 5400. The recommended dose for adults and pediatric patients is 200 mg on day 1 followed by once-daily maintenance doses of 100 mg for five days. However, the ‘drug will not be given to those with liver disease, kidney failure, pregnant or lactating women, and children below 12 years’. The drug will be available only through hospitals and the government.
The next batch of the drug will be shipped to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Kochi, Trivandrum and Goa. India has the fourth-highest number of Coronavirus cases in the world after the United States, Brazil and Russia.